Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Al Razi Medical Co's Total Liabilities for the quarter that ended in Jun. 2026 was ﷼29.83 Mil.
Al Razi Medical Co's quarterly Total Liabilities
increased
from Jun. 2025 (﷼27.07 Mil) to Dec. 2025 (﷼29.83 Mil) but then
stayed the same
from Dec. 2025 (﷼29.83 Mil) to Jun. 2026 (﷼29.83 Mil).
Al Razi Medical Co's annual Total Liabilities
declined
from Dec. 2023 (﷼23.05 Mil) to Dec. 2024 (﷼18.24 Mil) but then
increased
from Dec. 2024 (﷼18.24 Mil) to Dec. 2025 (﷼29.83 Mil).
Al Razi Medical Co Total Liabilities Related Terms
Al Razi Medical Co Total Liabilities Historical Data
* Premium members only.
The historical data trend for Al Razi Medical Co's Total Liabilities can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.
Al Razi Medical Co's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Al Razi Medical Co (SAU:9572) has a Total Liabilities of ﷼29.83 Mil as of Jun. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Al Razi Medical Co and its competitors.
Is Al Razi Medical Co's Total Liabilities too high?
Al Razi Medical Co's current Total Liabilities is ﷼29.83 Mil. Overall, Al Razi Medical Co has a GF Score™ of 55/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Al Razi Medical Co's Total Liabilities compare to competitors?
Al Razi Medical Co's Total Liabilities of ﷼29.83 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Healthcare Providers & Services company?
A good Total Liabilities depends on the Healthcare Providers & Services industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Al Razi Medical Co and its competitors. Al Razi Medical Co's current Total Liabilities is ﷼29.83 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Al Razi Medical Co stock overvalued right now?
Based on GuruFocus' analysis, Al Razi Medical Co (SAU:9572) is currently considered Significantly Undervalued. The stock's GF Value™ is ﷼56.91, compared to a current price of ﷼26.70 — trading 53.1% below its estimated fair value. The current Total Liabilities is ﷼29.83 Mil. Al Razi Medical Co's overall GF Score™ is 55/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Al Razi Medical Co (SAU:9572), the current Total Liabilities is ﷼29.83 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Al Razi Medical Co (SAU:9572) Overvalued in 2026?
Based on GuruFocus' analysis, Al Razi Medical Co stock appears to be undervalued.
The current stock price of ﷼26.70 is trading 53.1% below its estimated GF Value™ of ﷼56.91.
GuruFocus considers Al Razi Medical Co to be Significantly Undervalued.
Key valuation signals for SAU:9572:
Total Liabilities: ﷼29.83 Mil
GF Value™: ﷼56.91 vs. price of ﷼26.70 (53.1% below fair value)
No single metric tells the full story. See the SAU:9572 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Al Razi Medical Co operates in the medical field in the Kingdom of Saudi Arabia. The company provides all pharmaceutical and cosmetic products. It engages in buying and selling pharmaceuticals, medical supplies, herbal and cosmetic products, and all related products on a wholesale and retail basis.
55GF Score
Get the complete analysis for SAU:9572
Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:9572 has been successfully added to your 
